Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis
NCT04474990 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2025-08-24
Summary
Primary Objective: To treat a single patient with gastroparesis who has requested expanded access with tradipitant
Conditions
- Gastroparesis
- Diabetic Gastroparesis
Interventions
- DRUG
-
NK-1 Receptor antagonist
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Gastric Pacemaker Implantation for Gastroparesis
NCT00568373 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis
NCT00639808 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
NCT00612014 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
NCT01664637 ·Status: TERMINATED ·Phase: PHASE2
-
Thoracic Neuromodulation for Diabetic Gastroparesis
NCT05273788 ·Status: RECRUITING ·Phase: PHASE1
-
Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study
NCT04706832 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
NCT00595621 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
Gastric vs Jejunal Feeding in Diabetic Gastroparesis
NCT00944593 ·Status: WITHDRAWN ·Phase: PHASE4
-
Esophageal Food Impaction
NCT03305848 ·Status: COMPLETED ·Phase: PHASE4
-
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
NCT02267525 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
NCT06560307 ·Status: RECRUITING ·Phase: NA
-
Temporary Gastric Electrical Stimulation for Gastroparesis
NCT01054794 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
NCT02784392 ·Status: COMPLETED ·Phase: PHASE2
-
Enterra Therapy Gastric Stimulation System
NCT00556166 ·Status: TERMINATED ·Phase: PHASE4
-
Disposable Endoscope Platform in Third Space Endoscopic Procedures
NCT06738628 ·Status: NOT_YET_RECRUITING
-
Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)
NCT02776488 ·Status: WITHDRAWN ·Phase: PHASE2
-
Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis
NCT03123809 ·Status: COMPLETED ·Phase: NA
-
Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation
NCT02290626 ·Status: WITHDRAWN ·Phase: NA
-
Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome
NCT01895296 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Monocentric Study on the Efficacy of Lidocain Spray for Patient Comfort During Nasogastric Tube Insertion in Enteral Nutrition
NCT02022059 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Peritoneal Resuscitation in Gastroschisis
NCT03205553 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
NCT05993390 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study to Evaluate Safety of Nutriseal™ Nutriplace™ System
NCT03371160 ·Status: TERMINATED ·Phase: NA
-
Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age
NCT06643442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2